Management of Moderate Mitral Stenosis

Definition and Diagnosis

Moderate mitral stenosis is defined by a mitral valve area of 1.0-1.5 cm², representing clinically significant stenosis that requires structured management, though intervention is not automatically indicated as it would be in severe disease 1, 2

The European Society of Cardiology recommends diuretics for pulmonary congestion or peripheral edema in patients with moderate mitral stenosis 1, 3
Beta-blockers or rate-limiting calcium channel blockers are recommended to control heart rate, particularly important in atrial fibrillation to prolong diastolic filling time 1, 3
Digoxin is specifically recommended for heart rate control in patients with atrial fibrillation 1, 3
Anticoagulation with vitamin K antagonists (target INR 2-3) is indicated for new-onset or paroxysmal atrial fibrillation, history of systemic embolism, left atrial thrombus on imaging, dense spontaneous echocardiographic contrast, and enlarged left atrium 1, 2, 3

Asymptomatic patients with moderate mitral stenosis should undergo clinical and echocardiographic follow-up every 2-3 years 1, 4
More frequent monitoring (yearly) is recommended if approaching severe stenosis or if high-risk features develop 1
Stress testing is recommended when symptoms are equivocal or discordant with stenosis severity 2

Percutaneous mitral commissurotomy (PMC) may be considered in symptomatic patients with valve area >1.5 cm² if symptoms cannot be explained by another cause and valve anatomy is favorable 2
PMC should be considered in asymptomatic patients with moderate stenosis who have favorable anatomy and high thromboembolic risk or high risk of hemodynamic decompensation 1, 2

The European Society of Cardiology recommends severe emphasis on intervention before or during pregnancy, even for moderate stenosis, due to increased heart rate and stroke volume 7, 6
PMC should be evaluated in pregnant patients with symptomatic moderate-to-severe stenosis 2
Multidisciplinary cardio-obstetric team management is essential for pregnant patients with mitral stenosis 5

Delaying anticoagulation in patients with enlarged left atrium or dense spontaneous contrast is a common pitfall, as these patients have significant embolic risk even without atrial fibrillation 1, 3
Using NOACs instead of warfarin in patients with atrial fibrillation is contraindicated in mitral stenosis 1, 3
Assuming medical therapy prevents progression of mitral stenosis is incorrect, as it only provides symptom relief; regular monitoring for intervention indications is essential 3
Overlooking stress testing when symptoms seem discordant with resting hemodynamics can lead to underdiagnosis of significant stenosis 2, 7
Attempting PMC in degenerative mitral stenosis is not recommended, as it will fail due to lack of commissural fusion and may cause harm 4